NDC 73554-3111

Zynteglo

Betibeglogene Autotemcel

Zynteglo is a Intravenous Suspension in the Cellular Therapy category. It is labeled and distributed by Bluebird Bio, Inc.. The primary component is Betibeglogene Autotemcel.

• Product ID: 73554-3111_f45a90ae-d8b0-43ce-a560-b906e33c9e23
• NDC: 73554-3111
• Product Type: Cellular Therapy
• Proprietary Name: Zynteglo
• Generic Name: Betibeglogene Autotemcel
• Dosage Form: Suspension
• Route of Administration: INTRAVENOUS
• Marketing Start Date: 2022-08-17
• Marketing Category: BLA /
• Application Number: BLA125717
• Labeler Name: bluebird bio, Inc.
• Substance Name: BETIBEGLOGENE AUTOTEMCEL
• Active Ingredient Strength: 20000000 1/1
• NDC Exclude Flag: N
• Listing Certified Through: 2023-12-31

Packaging

NDC 73554-3111-1

1 SUSPENSION in 1 BAG (73554-3111-1)

• Marketing Start Date: 2022-08-17
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details